BamSEC and AlphaSense Join Forces
Learn More

Longboard Pharmaceuticals Inc. – Material Contracts

Formerly NASDAQ: LBPH
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.2
from 10-Q 4 pages Longboard Pharmaceuticals, Inc. Non-Employee Director Compensation Policy Amended and Restated: May 23, 2024
12/34/56
EX-10.1
from 10-Q 38 pages Longboard Pharmaceuticals, Inc. 2021 Equity Incentive Plan Adopted by the Board of Directors: February 28, 2021 Approved by the Stockholders: March 5, 2021 Amended and Restated by the Compensation Committee: October 19, 2023 Amended and Restated by the Compensation Committee: May 23, 2024
12/34/56
EX-10.1
from 10-Q 10 pages Non-Voting Common Stock Purchase Agreement
12/34/56
EX-10.6
from 10-K 9 pages Longboard Pharmaceuticals, Inc. Restricted Stock Unit Grant Notice
12/34/56
EX-10.4
from 10-K 38 pages Longboard Pharmaceuticals, Inc. 2021 Equity Incentive Plan Adopted by the Board of Directors: February 28, 2021 Approved by the Stockholders: March 5, 2021 Amended and Restated by the Compensation Committee: October 19, 2023
12/34/56
EX-10.1
from 10-Q 3 pages Longboard Pharmaceuticals, Inc. Non-Employee Director Compensation Policy Amended and Restated: May 25, 2023
12/34/56
EX-10.1
from 10-Q 9 pages Second Amendment to License Agreement
12/34/56
EX-10.3
from 10-Q 13 pages March 17, 2022 Randall E. Kaye, M.D. via Email Re: Offer of Employment Dear Randall: Longboard Pharmaceuticals, Inc. (The “Company”) Is Pleased to Offer You At-Will Employment in the Position of Chief Medical Officer (“Cmo”) Under the Terms and Conditions Set Forth in This Employment Agreement (The “Agreement”). 1
12/34/56
EX-10.2
from 10-Q 10 pages March 17, 2022 Philip Perera via Email Re: Retirement and Consulting Agreement Dear Philip: This Letter Sets Forth the Substance of the Retirement and Consulting Agreement (The “Agreement”) That Longboard Pharmaceuticals, Inc. (“Longboard”)) Is Offering to You in Connection With Your Employment Termination. 1. Retirement and Employment Resignation. You Have Informed Longboard That You Are Retiring and Resigning as the Chief Medical Officer of Longboard, as Well as From Any Other Positions You May Hold as an Employee of Longboard, Effective as of March 21, 2022 (Your “Retirement Date”). 2
12/34/56
EX-10.14
from 10-K 11 pages First Amendment to License Agreement
12/34/56
EX-10.16
from S-1/A 9 pages Exchange Agreement
12/34/56
EX-10.12
from S-1/A 11 pages March 1, 2021 Brandi Roberts via Email Re: Offer of Employment Dear Brandi
12/34/56
EX-10.11
from S-1/A 11 pages March 1, 2021 Philip Perera, M.D. via Email Re: Offer of Employment Dear Philip
12/34/56
EX-10.10
from S-1/A 11 pages March 1, 2021 Kevin Lind via Email Re: Offer of Employment Dear Kevin
12/34/56
EX-10.9
from S-1/A 3 pages Longboard Pharmaceuticals, Inc. Non-Employee Director Compensation Policy Adopted: February 28, 2021
12/34/56
EX-10.7
from S-1/A 5 pages Longboard Pharmaceuticals, Inc. Performance Bonus Plan
12/34/56
EX-10.6
from S-1/A 12 pages Longboard Pharmaceuticals, Inc. 2021 Employee Stock Purchase Plan Adopted by the Board of Directors: February 28, 2021 Approved by the Stockholders: March 5, 2021
12/34/56
EX-10.5
from S-1/A 11 pages Longboard Pharmaceuticals, Inc. Stock Option Grant Notice
12/34/56
EX-10.4
from S-1/A 36 pages Longboard Pharmaceuticals, Inc. 2021 Equity Incentive Plan Adopted by the Board of Directors: February 28, 2021 Approved by the Stockholders: March 5, 2021
12/34/56
EX-10.3
from S-1/A 43 pages Longboard Pharmaceuticals, Inc. Restricted Stock Award Grant Notice
12/34/56